Clarification from Russian expert organization regarding telmisartan BE studies [Regulatives / Guidelines]

posted by Beholder  – Russia, 2019-11-08 08:51 (2424 d 23:30 ago) – Posting: # 20764
Views: 9,622
(edited on 2019-11-08 11:27)

Hi to all!

An article which might serve as "guideline" for conducting telmisartan BE studies in Russia written by expert organization representative. Open access and abstract in English is available.

Main points represented in the article:
  1. 7 BE studies performed in Russia were assessed.
  2. Not only males should be enrolled but females as well (50/50).
  3. HPLC FLD is, in some cases, more sensitive than HPLC MS/MS (see study 3) ;-).
—
Best regards
Beholder

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
353 visitors (0 registered, 353 guests [including 13 identified bots]).
Forum time: 09:21 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5